AXIS 1 "RESEARCH, TECHNOLOGICAL DEVELOPMENT AND INNOVATION ACTION 1.1.4 “Support for collaborative R&D activities for the development of new sustainable technologies, products and services”
PRELIMINARY EFFICACY STUDY OF A FOOD SUPPLEMENT TO SUPPORT NCGS (Non-celiac gluten sensitivity) AND COELIAC DISEASE
Design and manufacture of a food supplement containing a plant enzyme and a probiotic. Study of the plant enzyme's proteolytic activity against gluten and the anti-inflammatory activity of the combination of active ingredients. Development of the finished product to improve its stability in terms of the viability of the probiotic strain.
Intervention realised with funding POR FESR 2014-2020 (Objective: '"Increasing business innovation activity").
Intervention carried out with the benefit of a grant from Regione Veneto amounting to euro 79.150.
PRODUCTION AND CHARACTERISATION OF AN AMARANTH EXTRACT FOR CARDIOVASCULAR HEALTH
Investigation and development of a food alternative with a health-promoting effect on the cardiovascular system. Field and vertical cultivations of different varieties of Amaranthus caudatus, production and characterisation of fluid extracts and simultaneous evaluation of biological activity.
Intervention realised with funding POR FESR 2014-2020 (Objective: "Increasing business innovation activity").
Intervention carried out with the benefit of a grant from Regione Veneto amounting to euro 35.375.
Thanks to the Regione Veneto and the European Union, Labomar has obtained important funding for the development of botanical extracts and food supplements to support health.
The precise study of products and the acquisition of new skills will enable Labomar to make important improvements in the production, proposition and positioning of its products.
Our focus is always on improving the entire production chain, services and the continuous raising of our quality standards, so that we can also address the most important international brands.
“Certified B Corporation” is a trademark licensed by B Lab, a private non-profit organization, to companies like ours that have successfully completed the B Impact Assessment (“BIA”) and therefore meet the requirements set by B Lab for social and environmental performance, accountability, and transparency. It is specified that B Lab is not a conformity assessment body as defined by Regulation (EU) No 765/2008, nor is it a national, European, or international standardization body as per Regulation (EU) No 1025/2012. The criteria of the BIA are distinct and independent from the harmonized standards resulting from ISO norms or other standardization bodies, and they are not ratified by national or European public institutions.
Our companies
The Labomar Group is always poised to capitalise on new opportunities and establish its presence in global markets. The Group’s sustained growth is also a result of acquiring and integrating companies situated in different geographical regions, engaged in businesses that complement our own.
Labomar Canada
Established in 1990 in Montreal, Canada, Labomar Canada is a pharmaceutical company with more than 30 years’ experience in the North America pharmaceutical, cosmetic and nutraceutical sector. Its core business area is the development, production and packaging of top-quality liquid, semi-solid and cream products for the pharmaceutical, cosmetic and nutraceutical industry. It became part of the Labomar Group in 2019.
Established in 2000 by Fulvia Lazzarotto and Franco De Bernardini, the Welcare Group is an outstanding Italian company which designs, manufactures and sells medical devices to prevent and treat infection and manage different kinds of skin lesions. It is headquartered in Orvieto (Terni), Italy and operates in 22 countries around the globe including Europe, the Middle East, South America and Australia. It became part of the Labomar Group in 2021.
Founded in 2011, Labiotre brings together professionals with years of experience in the extraction of medicinal herbs and the formulation of food supplements. Located in the heart of the Chianti region in Tuscany, it produces plant extracts using innovative techniques which are titrated in active ingredients with documented physiological action. It conducts exclusive clinical trials on specific extracts or fractions at the client’s discretion and request. It can also study the active ingredients of the extract from a technological point of view using the latest pharmaceutical techniques. Labiotre also produces bovine, fish and plant-based gelatin softgel, in compliance with the highest quality standards. Labomar Spa is one of the founding shareholders of Labiotre Srl and, in November 2021, it acquired the entire share capital, with a view to creating highly efficient supply chain integration.
With more than 25 years of experience in the development and manufacture of products for the pharma & cosmetics industry, at Entema Laboratories, is a reliable CDMO focused on cosmetic, sanitary, hygiene, antiseptic, zoosanitary products and food supplement products. Entema’s Team gives a full service support to its clients, from the formulation and the samples development to the delivery of the finished product.